RTOG-9601
Terminated
Protocol Information
Tab containing protocol details, study design, and eligibility criteria
Tab containing study documents, informed consent forms, and study materials
Tab containing information for potential study participants
A Phase III Trial of Radiation Therapy with or without Casodex in Patients with PSA Elevation Following Radical Prostatectomy for pT3N0 Carcinoma of the Prostate
Principal Investigator
William U. Shipley
Status
Terminated
Date of Study Termination
May 20, 2022
Disease Site
Genitourinary [GU] Prostate
Phase
III
Developmental Therapeutics
No
Patient Population
–
Target Accrual
810
Protocol Documents
Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.